{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T15:28:24Z","timestamp":1788449304983,"version":"build-2803163510"},"reference-count":104,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,5]],"date-time":"2021-02-05T00:00:00Z","timestamp":1612483200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_173010"],"award-info":[{"award-number":["310030_173010"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["310030_185318\/1"],"award-info":[{"award-number":["310030_185318\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["CRSII3_160772\/1"],"award-info":[{"award-number":["CRSII3_160772\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["CRSII5_170929"],"award-info":[{"award-number":["CRSII5_170929"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004955","name":"\u00d6sterreichische Forschungsf\u00f6rderungsgesellschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004955","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.xcrm.2021.100209","type":"journal-article","created":{"date-parts":[[2021,3,7]],"date-time":"2021-03-07T15:48:56Z","timestamp":1615132136000},"page":"100209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T\u00a0cell attack"],"prefix":"10.1016","volume":"2","author":[{"given":"Weldy V.","family":"Bonilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Kirchhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Friederike","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra M.","family":"Kallert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena A.","family":"Krzyzaniak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Darbre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josipa","family":"Raguz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula","family":"Berka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilena","family":"Vincenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mindaugas","family":"Pauzuolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8152-8189","authenticated-orcid":false,"given":"Romy","family":"Kerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Hoepner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"G\u00fcnther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1125-2783","authenticated-orcid":false,"given":"Carsten","family":"Magnus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Merkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus K.","family":"Orlinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Zippelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1594-3189","authenticated-orcid":false,"given":"Daniel D.","family":"Pinschewer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2021.100209_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa020177","article-title":"Intratumoral T\u00a0cells, recurrence, and survival in epithelial ovarian cancer","volume":"348","author":"Zhang","year":"2003","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib2","doi-asserted-by":"crossref","first-page":"2654","DOI":"10.1056\/NEJMoa051424","article-title":"Effector memory T\u00a0cells, early metastasis, and survival in colorectal cancer","volume":"353","author":"Pag\u00e8s","year":"2005","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib3","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1126\/science.1129139","article-title":"Type, density, and location of immune cells within human colorectal tumors predict clinical outcome","volume":"313","author":"Galon","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2021.100209_bib4","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100209_bib5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1084\/jem.189.6.991","article-title":"Dramatic rise in plasma viremia after CD8(+) T\u00a0cell depletion in simian immunodeficiency virus-infected macaques","volume":"189","author":"Jin","year":"1999","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib6","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1126\/science.283.5403.857","article-title":"Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes","volume":"283","author":"Schmitz","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2021.100209_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.coviro.2017.03.011","article-title":"Therapeutic vaccination for chronic hepatitis B","volume":"23","author":"Kosinska","year":"2017","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.xcrm.2021.100209_bib8","doi-asserted-by":"crossref","first-page":"334ps339","DOI":"10.1126\/scitranslmed.aaf0685","article-title":"The Human Vaccines Project: A roadmap for cancer vaccine development","volume":"8","author":"Romero","year":"2016","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/nature23093","article-title":"Cancer: Precision T-cell therapy targets tumours","volume":"547","author":"Melief","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100209_bib10","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1056\/NEJMoa1001294","article-title":"Sipuleucel-T immunotherapy for castration-resistant prostate cancer","volume":"363","author":"Kantoff","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib11","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1470-2045(16)00099-1","article-title":"Efficacy of the MAGE-A3 cancer immunotherapeutic as adjuvant therapy in patients with resected MAGE-A3-positive non-small-cell lung cancer (MAGRIT): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"17","author":"Vansteenkiste","year":"2016","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2021.100209_bib12","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S1470-2045(13)70510-2","article-title":"Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial","volume":"15","author":"Butts","year":"2014","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.xcrm.2021.100209_bib13","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1200\/JCO.18.02031","article-title":"Phase III Trial of PROSTVAC in Asymptomatic or Minimally Symptomatic Metastatic Castration-Resistant Prostate Cancer","volume":"37","author":"Gulley","year":"2019","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2021.100209_bib14","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/nm1100","article-title":"Cancer immunotherapy: moving beyond current vaccines","volume":"10","author":"Rosenberg","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib15","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1038\/ni.2703","article-title":"Innate and adaptive immune cells in the tumor microenvironment","volume":"14","author":"Gajewski","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib16","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2021.100209_bib17","doi-asserted-by":"crossref","first-page":"226ra32","DOI":"10.1126\/scitranslmed.3008095","article-title":"Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy","volume":"6","author":"Zamarin","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib18","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1093\/jnci\/87.13.982","article-title":"Generation of human cytotoxic T\u00a0cells specific for human carcinoembryonic antigen epitopes from patients immunized with recombinant vaccinia-CEA vaccine","volume":"87","author":"Tsang","year":"1995","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.xcrm.2021.100209_bib19","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1200\/JCO.2009.25.0597","article-title":"Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer","volume":"28","author":"Kantoff","year":"2010","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.xcrm.2021.100209_bib20","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1172\/JCI42672","article-title":"An alphavirus vector overcomes the presence of neutralizing antibodies and elevated numbers of Tregs to induce immune responses in humans with advanced cancer","volume":"120","author":"Morse","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2021.100209_bib21","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12967-020-02228-9","article-title":"Safety, tolerability and immunogenicity of V934\/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study","volume":"18","author":"Aurisicchio","year":"2020","journal-title":"J.\u00a0Transl. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib22","series-title":"A Phase 1 Study To Evaluate Escalating Doses Of A Vaccine-Based Immunotherapy Regimen For Prostate Cancer (PrCa VBIR)","year":"2020"},{"key":"10.1016\/j.xcrm.2021.100209_bib23","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/CJI.0000000000000183","article-title":"First-in-Human Treatment With a Dendritic Cell-targeting Lentiviral Vector-expressing NY-ESO-1, LV305, Induces Deep, Durable Response in Refractory Metastatic Synovial Sarcoma Patient","volume":"40","author":"Pollack","year":"2017","journal-title":"J.\u00a0Immunother."},{"key":"10.1016\/j.xcrm.2021.100209_bib24","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/j.vaccine.2018.02.070","article-title":"Preclinical development of peptide vaccination combined with oncolytic MG1-E6E7 for HPV-associated cancer","volume":"36","author":"Atherton","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2021.100209_bib25","series-title":"This is a Trial of MG1-E6E7 With Ad-E6E7 and Atezolizumab in Patients With HPV Associated Cancers (Kingfisher)","year":"2020"},{"key":"10.1016\/j.xcrm.2021.100209_bib26","doi-asserted-by":"crossref","first-page":"w14465","DOI":"10.4414\/smw.2017.14465","article-title":"Virally vectored vaccine delivery: medical needs, mechanisms, advantages and challenges","volume":"147","author":"Pinschewer","year":"2017","journal-title":"Swiss Med. Wkly."},{"key":"10.1016\/j.xcrm.2021.100209_bib27","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1084\/jem.20051720","article-title":"Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity","volume":"203","author":"Querec","year":"2006","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib28","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.it.2016.03.007","article-title":"IL-33 in T Cell Differentiation, Function, and Immune Homeostasis","volume":"37","author":"Peine","year":"2016","journal-title":"Trends Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib29","doi-asserted-by":"crossref","first-page":"15327","DOI":"10.1038\/ncomms15327","article-title":"Replicating viral vector platform exploits alarmin signals for potent CD8(+) T\u00a0cell-mediated tumour immunotherapy","volume":"8","author":"Kallert","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2021.100209_bib30","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1073\/pnas.1418549112","article-title":"T-bet- and STAT4-dependent IL-33 receptor expression directly promotes antiviral Th1 cell responses","volume":"112","author":"Baumann","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100209_bib31","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1126\/science.1215418","article-title":"The alarmin interleukin-33 drives protective antiviral CD8+ T\u00a0cell responses","volume":"335","author":"Bonilla","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2021.100209_bib32","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1056\/NEJMoa1817307","article-title":"Phase 3 Efficacy Trial of Modified Vaccinia Ankara as a Vaccine against Smallpox","volume":"381","author":"Pittman","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib33","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1016\/0264-410X(93)90079-D","article-title":"Vaccination with two different vaccinia recombinant viruses: long-term inhibition of secondary vaccination","volume":"11","author":"K\u00fcndig","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2021.100209_bib34","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/S0140-6736(08)61592-5","article-title":"HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis","volume":"372","author":"McElrath","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.xcrm.2021.100209_bib35","doi-asserted-by":"crossref","first-page":"115ra112","DOI":"10.1126\/scitranslmed.3002925","article-title":"Vaccine vectors derived from a large collection of simian adenoviruses induce potent cellular immunity across multiple species","volume":"4","author":"Colloca","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib36","doi-asserted-by":"crossref","first-page":"115ra111","DOI":"10.1126\/scitranslmed.3003155","article-title":"Novel adenovirus-based vaccines induce broad and sustained T\u00a0cell responses to HCV in man","volume":"4","author":"Barnes","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib37","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/nm.3702","article-title":"Chimpanzee adenovirus vaccine generates acute and durable protective immunity against ebolavirus challenge","volume":"20","author":"Stanley","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib38","first-page":"1","article-title":"Lymphocytic choriomeningitis virus and immunology","volume":"263","author":"Zinkernagel","year":"2002","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib39","doi-asserted-by":"crossref","first-page":"4663","DOI":"10.1073\/pnas.0600652103","article-title":"Recovery of an arenavirus entirely from RNA polymerase I\/II-driven cDNA","volume":"103","author":"Flatz","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100209_bib40","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.virol.2006.01.012","article-title":"Rescue of the prototypic Arenavirus LCMV entirely from plasmid","volume":"350","author":"S\u00e1nchez","year":"2006","journal-title":"Virology"},{"key":"10.1016\/j.xcrm.2021.100209_bib41","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/nm.2104","article-title":"Development of replication-defective lymphocytic choriomeningitis virus vectors for the induction of potent CD8+ T\u00a0cell immunity","volume":"16","author":"Flatz","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib42","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1128\/JVI.00599-12","article-title":"Gene-based vaccination with a mismatched envelope protects against simian immunodeficiency virus infection in nonhuman primates","volume":"86","author":"Flatz","year":"2012","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2021.100209_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vaccine.2016.11.063","article-title":"Development of novel replication-defective lymphocytic choriomeningitis virus vectors expressing SIV antigens","volume":"35","author":"Penaloza MacMaster","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2021.100209_bib44","first-page":"jiaa121","article-title":"A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus","volume":"2020","author":"Schwendinger","year":"2020","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100209_bib45","doi-asserted-by":"crossref","first-page":"e1005276","DOI":"10.1371\/journal.ppat.1005276","article-title":"Arenavirus Glycan Shield Promotes Neutralizing Antibody Evasion and Protracted Infection","volume":"11","author":"Sommerstein","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2021.100209_bib46","series-title":"A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients","year":"2021"},{"key":"10.1016\/j.xcrm.2021.100209_bib47","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.0900088106","article-title":"Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest","volume":"106","author":"Emonet","year":"2009","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100209_bib48","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1128\/JVI.02705-15","article-title":"A Novel Live Pichinde Virus-Based Vaccine Vector Induces Enhanced Humoral and Cellular Immunity after a Booster Dose","volume":"90","author":"Dhanwani","year":"2015","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2021.100209_bib49","series-title":"A Study of TheraT\u00ae Vector(s) Expressing HPV 16+ in Patients With HPV 16+ Confirmed Cancers","year":"2020"},{"key":"10.1016\/j.xcrm.2021.100209_bib50","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1086\/514211","article-title":"Protective efficacy of a live attenuated vaccine against Argentine hemorrhagic fever","volume":"177","author":"Maiztegui","year":"1998","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.xcrm.2021.100209_bib51","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1128\/iai.9.5.821-823.1974","article-title":"Serological evidence of infection by Pichinde virus among laboratory workers","volume":"9","author":"Buchmeier","year":"1974","journal-title":"Infect. Immun."},{"key":"10.1016\/j.xcrm.2021.100209_bib52","first-page":"129","article-title":"Some recent research in the field of neurotropic viruses with especial reference to lymphocytic choriomeningitis and herpes simplex","volume":"91","author":"Armstrong","year":"1942","journal-title":"Mil. Surg."},{"key":"10.1016\/j.xcrm.2021.100209_bib53","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1056\/NEJMcpc1904042","article-title":"Case 40-2019: A 26-Year-Old Returning Traveler with Headache","volume":"381","author":"Stone","year":"2019","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib54","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1177\/0883073814529820","article-title":"Protracted symptoms in lymphocytic choriomeningitis: a case report","volume":"30","author":"Souders","year":"2015","journal-title":"J.\u00a0Child Neurol."},{"key":"10.1016\/j.xcrm.2021.100209_bib55","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.vaccine.2003.07.003","article-title":"Antitumor efficacy of Venezuelan equine encephalitis virus replicon particles encoding mutated HPV16 E6 and E7 genes","volume":"22","author":"Cassetti","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.xcrm.2021.100209_bib56","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1371\/journal.ppat.0020051","article-title":"Envelope exchange for the generation of live-attenuated arenavirus vaccines","volume":"2","author":"Bergthaler","year":"2006","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.xcrm.2021.100209_bib57","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1093\/brain\/awq028","article-title":"T cells can mediate viral clearance from ependyma but not from brain parenchyma in a major histocompatibility class I- and perforin-independent manner","volume":"133","author":"Pinschewer","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.xcrm.2021.100209_bib58","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.4049\/jimmunol.176.7.4235","article-title":"CXCL10 is the key ligand for CXCR3 on CD8+ effector T\u00a0cells involved in immune surveillance of the lymphocytic choriomeningitis virus-infected central nervous system","volume":"176","author":"Christensen","year":"2006","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib59","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/238335a0","article-title":"Requirement for theta-bearing cells in lymphocytic choriomeningitis virus-induced central nervous system disease","volume":"238","author":"Cole","year":"1972","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100209_bib60","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/ni723","article-title":"Promiscuous gene expression in medullary thymic epithelial cells mirrors the peripheral self","volume":"2","author":"Derbinski","year":"2001","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib61","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/(SICI)1097-0215(19970127)70:3<349::AID-IJC17>3.0.CO;2-A","article-title":"The expression of mouse gene P1A in testis does not prevent safe induction of cytolytic T\u00a0cells against a P1A-encoded tumor antigen","volume":"70","author":"Uyttenhove","year":"1997","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.xcrm.2021.100209_bib62","doi-asserted-by":"crossref","first-page":"111","DOI":"10.4049\/jimmunol.1002612","article-title":"Minimal tolerance to a tumor antigen encoded by a cancer-germline gene","volume":"188","author":"Huijbers","year":"2012","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib63","doi-asserted-by":"crossref","first-page":"8306","DOI":"10.1038\/ncomms9306","article-title":"Functional classification of memory CD8(+) T\u00a0cells by CX3CR1 expression","volume":"6","author":"B\u00f6ttcher","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2021.100209_bib64","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/j.immuni.2016.10.018","article-title":"The Chemokine Receptor CX3CR1 Defines Three Antigen-Experienced CD8\u00a0T Cell Subsets with Distinct Roles in Immune Surveillance and Homeostasis","volume":"45","author":"Gerlach","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2021.100209_bib65","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/j.immuni.2013.05.009","article-title":"Effector-like CD8+ T\u00a0cells in the memory population mediate potent protective immunity","volume":"38","author":"Olson","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2021.100209_bib66","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.immuni.2007.07.010","article-title":"Inflammation directs memory precursor and short-lived effector CD8(+) T\u00a0cell fates via the graded expression of T-bet transcription factor","volume":"27","author":"Joshi","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2021.100209_bib67","doi-asserted-by":"crossref","first-page":"4838","DOI":"10.4049\/jimmunol.167.9.4838","article-title":"Viral infections induce abundant numbers of senescent CD8 T\u00a0cells","volume":"167","author":"Voehringer","year":"2001","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib68","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/80877","article-title":"CD27 is required for generation and long-term maintenance of T\u00a0cell immunity","volume":"1","author":"Hendriks","year":"2000","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib69","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.immuni.2016.07.021","article-title":"T Cell Factor 1-Expressing Memory-like CD8(+) T Cells Sustain the Immune Response to Chronic Viral Infections","volume":"45","author":"Utzschneider","year":"2016","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2021.100209_bib70","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-60327-118-9_5","article-title":"SYFPEITHI: database for searching and T-cell epitope prediction","volume":"409","author":"Schuler","year":"2007","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.xcrm.2021.100209_bib71","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/351290a0","article-title":"Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules","volume":"351","author":"Falk","year":"1991","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100209_bib72","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.immuni.2015.05.001","article-title":"Clonal Deletion Prunes but Does Not Eliminate Self-Specific \u03b1\u03b2 CD8(+) T Lymphocytes","volume":"42","author":"Yu","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2021.100209_bib73","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8\u00a0T Cell Exhaustion During Chronic Viral Infection and Cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib74","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/nri3740","article-title":"T cell differentiation in chronic infection and cancer: functional adaptation or exhaustion?","volume":"14","author":"Speiser","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib75","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/ni.2606","article-title":"T cells maintain an exhausted phenotype after antigen withdrawal and population reexpansion","volume":"14","author":"Utzschneider","year":"2013","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib76","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/PPO.0b013e3182325e63","article-title":"Viral vector-based therapeutic cancer vaccines","volume":"17","author":"Larocca","year":"2011","journal-title":"Cancer J."},{"key":"10.1016\/j.xcrm.2021.100209_bib77","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1182\/blood-2012-06-438481","article-title":"Delivery of viral-vectored vaccines by B cells represents a novel strategy to accelerate CD8(+) T-cell recall responses","volume":"121","author":"Zhang","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.xcrm.2021.100209_bib78","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1537-2995.2007.01081.x","article-title":"Prevalence of antibodies to lymphocytic choriomeningitis virus in blood donors in southeastern France","volume":"47","author":"de Lamballerie","year":"2007","journal-title":"Transfusion"},{"key":"10.1016\/j.xcrm.2021.100209_bib79","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/jmv.10389","article-title":"Lymphocytic choriomeningitis virus infection in a province of Spain: analysis of sera from the general population and wild rodents","volume":"70","author":"Lled\u00f3","year":"2003","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.xcrm.2021.100209_bib80","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1080\/01652176.1999.9694991","article-title":"Low prevalence of antibodies against the zoonotic agents Brucella abortus, Leptospira spp., Streptococcus suis serotype II, hantavirus, and lymphocytic choriomeningitis virus among veterinarians and pig farmers in the southern part of The Netherlands","volume":"21","author":"Elbers","year":"1999","journal-title":"Vet. Q."},{"key":"10.1016\/j.xcrm.2021.100209_bib81","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/jmv.1890380107","article-title":"Prevalence of serum antibodies against lymphocytic choriomeningitis virus in selected populations from two U.S. cities","volume":"38","author":"Stephensen","year":"1992","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.xcrm.2021.100209_bib82","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nature20583","article-title":"Ad26\/MVA therapeutic vaccination with TLR7 stimulation in SIV-infected rhesus monkeys","volume":"540","author":"Borducchi","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100209_bib83","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature04721","article-title":"Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity","volume":"441","author":"Roberts","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.xcrm.2021.100209_bib84","doi-asserted-by":"crossref","first-page":"8431","DOI":"10.4049\/jimmunol.175.12.8431","article-title":"Immunodominance of poxviral-specific CTL in a human trial of recombinant-modified vaccinia Ankara","volume":"175","author":"Smith","year":"2005","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib85","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1172\/JCI60202","article-title":"Human adenovirus-specific T\u00a0cells modulate HIV-specific T\u00a0cell responses to an Ad5-vectored HIV-1 vaccine","volume":"122","author":"Frahm","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.xcrm.2021.100209_bib86","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nm.1991","article-title":"Adenovirus-specific immunity after immunization with an Ad5 HIV-1 vaccine candidate in humans","volume":"15","author":"O\u2019Brien","year":"2009","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib87","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1128\/JVI.01689-07","article-title":"Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy","volume":"82","author":"Leen","year":"2008","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2021.100209_bib88","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.192.8.1105","article-title":"T cells compete for access to antigen-bearing antigen-presenting cells","volume":"192","author":"Kedl","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib89","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.4049\/jimmunol.163.12.6462","article-title":"The in\u00a0vivo fate of APCs displaying minor H antigen and\/or MHC differences is regulated by CTLs specific for immunodominant class I-associated epitopes","volume":"163","author":"Loyer","year":"1999","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib90","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41541-019-0103-y","article-title":"Turning the corner on therapeutic cancer vaccines","volume":"4","author":"Hollingsworth","year":"2019","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.xcrm.2021.100209_bib91","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0166-0934(91)90018-U","article-title":"Quantification of lymphocytic choriomeningitis virus with an immunological focus assay in 24- or 96-well plates","volume":"33","author":"Battegay","year":"1991","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.xcrm.2021.100209_bib92","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1128\/CVI.00163-09","article-title":"Characterization of monoclonal antibodies to Junin virus nucleocapsid protein and application to the diagnosis of hemorrhagic fever caused by South American arenaviruses","volume":"16","author":"Nakauchi","year":"2009","journal-title":"Clin. Vaccine Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib93","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/BF01313953","article-title":"Epitope mapping of the Lassa virus nucleoprotein using monoclonal anti-nucleocapsid antibodies","volume":"106","author":"Hufert","year":"1989","journal-title":"Arch. Virol."},{"key":"10.1016\/j.xcrm.2021.100209_bib94","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.4049\/jimmunol.171.10.5415","article-title":"Immunodominance of an antiviral cytotoxic T\u00a0cell response is shaped by the kinetics of viral protein expression","volume":"171","author":"Probst","year":"2003","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib95","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1084\/jem.191.5.795","article-title":"Immunotherapy with dendritic cells directed against tumor antigens shared with normal host cells results in severe autoimmune disease","volume":"191","author":"Ludewig","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib96","first-page":"21","article-title":"Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen","volume":"56","author":"Lin","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2021.100209_bib97","doi-asserted-by":"crossref","first-page":"e1006650","DOI":"10.1371\/journal.pcbi.1006650","article-title":"BEAST 2.5: An advanced software platform for Bayesian evolutionary analysis","volume":"15","author":"Bouckaert","year":"2019","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.xcrm.2021.100209_bib98","doi-asserted-by":"crossref","first-page":"4748","DOI":"10.1128\/JVI.73.6.4748-4754.1999","article-title":"Role of the individual interferon systems and specific immunity in mice in controlling systemic dissemination of attenuated pseudorabies virus infection","volume":"73","author":"Grob","year":"1999","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.xcrm.2021.100209_bib99","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/intimm\/5.6.647","article-title":"Immunoglobulin gene rearrangement in B cell deficient mice generated by targeted deletion of the JH locus","volume":"5","author":"Chen","year":"1993","journal-title":"Int. Immunol."},{"key":"10.1016\/j.xcrm.2021.100209_bib100","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1084\/jem.191.6.1069","article-title":"T1\/ST2-deficient mice demonstrate the importance of T1\/ST2 in developing primary T helper cell type 2 responses","volume":"191","author":"Townsend","year":"2000","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.xcrm.2021.100209_bib101","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1007\/s00705-008-0101-2","article-title":"Genome comparison of virulent and avirulent strains of the Pichinde arenavirus","volume":"153","author":"Lan","year":"2008","journal-title":"Arch. Virol."},{"key":"10.1016\/j.xcrm.2021.100209_bib102","doi-asserted-by":"crossref","first-page":"7895","DOI":"10.1073\/pnas.1332709100","article-title":"Recombinant lymphocytic choriomeningitis virus expressing vesicular stomatitis virus glycoprotein","volume":"100","author":"Pinschewer","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.xcrm.2021.100209_bib103","series-title":"Computer program distributed by author","year":"2018"},{"key":"10.1016\/j.xcrm.2021.100209_bib104","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jim.2012.06.005","article-title":"Area under the curve as a tool to measure kinetics of tumor growth in experimental animals","volume":"382","author":"Duan","year":"2012","journal-title":"J.\u00a0Immunol. Methods"}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121000203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379121000203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T22:46:53Z","timestamp":1762987613000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379121000203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":104,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2666379121000203"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100209","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterologous arenavirus vector prime-boost overrules self-tolerance for efficient tumor-specific CD8 T\u00a0cell attack","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2021.100209","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100209"}}